We discuss the controversial FDA AdComm meeting for Biogen's aducanumab, a drug being developed to treat Alzheimer's disease.
Link to the FDA's website with AdComm materials: [ Ссылка ]
Ещё видео!
We discuss the controversial FDA AdComm meeting for Biogen's aducanumab, a drug being developed to treat Alzheimer's disease.
Link to the FDA's website with AdComm materials: [ Ссылка ]